ENTRY       D11856            Mixture   Drug
NAME        Empagliflozin, linagliptin and metformin hydrochloride;
            Trijardy xr (TN)
PRODUCT     TRIJARDY XR (Boehringer Ingelheim Pharmaceuticals)
COMPONENT   Empagliflozin [DR:D10459], Linagliptin [DR:D09566], Metformin hydrochloride [DR:D00944]
CLASS       Antidiabetic agent
             DG02044  Hypoglycemic agent
              DG03228  Combination of metformin, DPP-4 inhibitor and SGLT2 inhibitor
REMARK      ATC code: A10BD27
            Product: D11856<US>
EFFICACY    Antidiabetic
  DISEASE   Type 2 diabetes mellitus [DS:H00409]
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             A ALIMENTARY TRACT AND METABOLISM
              A10 DRUGS USED IN DIABETES
               A10B BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
                A10BD Combinations of oral blood glucose lowering drugs
                 A10BD27 Metformin, linagliptin and empagliflozin
                  D11856  Empagliflozin, linagliptin and metformin hydrochloride &lt;US&gt;
            USP drug classification [BR:br08302]
             Blood Glucose Regulators
              Antidiabetic Combinations
               Empagliflozin/ Linagliptin/ Metformin Hydrochloride
                D11856  Empagliflozin, linagliptin and metformin hydrochloride
            Drug groups [BR:br08330]
             Antidiabetic agent
              DG02044  Hypoglycemic agent
               DG03228  Combination of metformin, DPP-4 inhibitor and SGLT2 inhibitor
                D11856  Empagliflozin, linagliptin and metformin hydrochloride
            Drug classes [BR:br08332]
             Antidiabetic agent
              DG02044  Hypoglycemic agent
               D11856  Empagliflozin, linagliptin and metformin hydrochloride
///
